by asormani
Posted on: November 21, 2012 by asormaniNo Comments »
MabVax Therapeutics, a privately held clinical stage biotechnology company has closed the first tranche in a Series B financing. Numoda Capital Innovations led the round and was joined by existing investors Burrill Capital Fund IV and RTP Venture Fund for an aggregate investment of $5.25 million.
The surging popularity of bitcoin has some brand-name venture capitalists investing real money in the controversial virtual currency. Just since
Author : laragon
TPG has had much luck tapping the IPO market during the past 12 months. The PE firm’s most recent success
Author : lbeltran
This week marks the one-year anniversary of Facebook’s public offering, one of the most highly anticipated market events in Wall
Author : connieloizos
Blackstone Group LP is planning to create a hedge fund which will consist of the boldest trades from the third-party
Author : reuters-news
Long before taking the helm as CEO of Twitter, Dick Costolo was an aspiring comic at Chicago’s famed The Second
Author : joanna
Welcome! Join the peHUB community to make connections, share your opinion, and follow your favorite authors. It's quick and easy.
Click here to get started!
billyfink posted an update 4 minutes ago
Mahendra Ramsinghani commented on the post, Forget Midas; What We Really Need Is a Mygdon List 18 minutes ago
The link to Jerry Neumann’s list is broken and is being fixed – t should be
http://reactionwheel.blogspot.com/2013/05/midas-list-feeder-firms.html
Kirk Falconer wrote a new post, Welcome to peHUB Canada! 1 hour, 13 minutes ago
Kirk Falconer wrote a new post, Relay Ventures’ Big Score 1 hour, 46 minutes ago
Luisa Beltran wrote a new post, Bessemer Venture Leads $45 Mln Round for Adaptive Planning 2 hours, 17 minutes ago
Adaptive Planning said Tuesday it secured $45 million in venture funding led by Bessemer Venture Partners. Existing investors ONSET Ventures, Norwest Venture Partners (NVP), RBC Venture Partners, Cardinal Venture […]
